Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Payables (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Payables for 15 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables rose 656.78% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Sep 2025, up 656.78%, and an annual FY2024 reading of $1.5 million, down 22.05% over the prior year.
  • Payables was $1.1 million for Q3 2025 at Sanara MedTech, up from $32355.0 in the prior quarter.
  • Across five years, Payables topped out at $2.1 million in Q1 2025 and bottomed at $23289.0 in Q1 2023.
  • Average Payables over 5 years is $581695.8, with a median of $150611.0 recorded in 2024.
  • The sharpest move saw Payables tumbled 92.36% in 2021, then skyrocketed 5553.08% in 2023.
  • Year by year, Payables stood at $438154.0 in 2021, then plummeted by 92.23% to $34036.0 in 2022, then surged by 5553.08% to $1.9 million in 2023, then decreased by 22.05% to $1.5 million in 2024, then fell by 24.0% to $1.1 million in 2025.
  • Business Quant data shows Payables for SMTI at $1.1 million in Q3 2025, $32355.0 in Q2 2025, and $2.1 million in Q1 2025.